Asthma exacerbations: Key points from the NIH guidelines

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Prompt assessment and aggressive treatment are crucial to effectively managing asthma exacerbations. At home, the patient should quickly assess his or her status and take a β2-agonist, 4 puffs by metered-dose inhaler every 20 minutes or a single nebulizer dose. If 1 hour later peak expiratory flow is less than 50% of baseline, the patient should add an oral corticosteroid to his regimen and immediately call you or go to the emergency department (ED). The primary therapies for an exacerbation in the ED, clinic, and hospital are oxygen supplementation, inhaled β2-agonists, and systemic corticosteroids. Frequent reassessments and careful modifications of treatment minimize the risk of respiratory failure and the need for hospitalization.

Original languageEnglish (US)
Pages (from-to)346-363
Number of pages18
JournalJournal of Respiratory Diseases
Volume19
Issue number4
StatePublished - 1998

Fingerprint

Asthma
Guidelines
Hospital Emergency Service
Adrenal Cortex Hormones
Metered Dose Inhalers
Nebulizers and Vaporizers
Respiratory Insufficiency
Hospitalization
Therapeutics
Oxygen

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Asthma exacerbations : Key points from the NIH guidelines. / Peters, Jay I.

In: Journal of Respiratory Diseases, Vol. 19, No. 4, 1998, p. 346-363.

Research output: Contribution to journalArticle

@article{c496030d54f84d97bf83fadc82646fcb,
title = "Asthma exacerbations: Key points from the NIH guidelines",
abstract = "Prompt assessment and aggressive treatment are crucial to effectively managing asthma exacerbations. At home, the patient should quickly assess his or her status and take a β2-agonist, 4 puffs by metered-dose inhaler every 20 minutes or a single nebulizer dose. If 1 hour later peak expiratory flow is less than 50{\%} of baseline, the patient should add an oral corticosteroid to his regimen and immediately call you or go to the emergency department (ED). The primary therapies for an exacerbation in the ED, clinic, and hospital are oxygen supplementation, inhaled β2-agonists, and systemic corticosteroids. Frequent reassessments and careful modifications of treatment minimize the risk of respiratory failure and the need for hospitalization.",
author = "Peters, {Jay I}",
year = "1998",
language = "English (US)",
volume = "19",
pages = "346--363",
journal = "Journal of Respiratory Diseases - For Pediatricians",
issn = "0194-259X",
publisher = "Cliggott Publishing Co.",
number = "4",

}

TY - JOUR

T1 - Asthma exacerbations

T2 - Key points from the NIH guidelines

AU - Peters, Jay I

PY - 1998

Y1 - 1998

N2 - Prompt assessment and aggressive treatment are crucial to effectively managing asthma exacerbations. At home, the patient should quickly assess his or her status and take a β2-agonist, 4 puffs by metered-dose inhaler every 20 minutes or a single nebulizer dose. If 1 hour later peak expiratory flow is less than 50% of baseline, the patient should add an oral corticosteroid to his regimen and immediately call you or go to the emergency department (ED). The primary therapies for an exacerbation in the ED, clinic, and hospital are oxygen supplementation, inhaled β2-agonists, and systemic corticosteroids. Frequent reassessments and careful modifications of treatment minimize the risk of respiratory failure and the need for hospitalization.

AB - Prompt assessment and aggressive treatment are crucial to effectively managing asthma exacerbations. At home, the patient should quickly assess his or her status and take a β2-agonist, 4 puffs by metered-dose inhaler every 20 minutes or a single nebulizer dose. If 1 hour later peak expiratory flow is less than 50% of baseline, the patient should add an oral corticosteroid to his regimen and immediately call you or go to the emergency department (ED). The primary therapies for an exacerbation in the ED, clinic, and hospital are oxygen supplementation, inhaled β2-agonists, and systemic corticosteroids. Frequent reassessments and careful modifications of treatment minimize the risk of respiratory failure and the need for hospitalization.

UR - http://www.scopus.com/inward/record.url?scp=0031970352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031970352&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031970352

VL - 19

SP - 346

EP - 363

JO - Journal of Respiratory Diseases - For Pediatricians

JF - Journal of Respiratory Diseases - For Pediatricians

SN - 0194-259X

IS - 4

ER -